Kidney News and Research

RSS

Researchers investigate how intestinal bacteria distribute metabolic products in membrane vesicles

Bacteria in the intestine pack a wide spectrum of their biomolecules into small capsules. These are transported via the bloodstream to various organs in the body and even absorbed and processed by nerve cells in the brain.

9 Nov 2021

SARS-CoV-2 infection regulates protein arginylation

A new study explores the role of arginylation during SARS-CoV-2 infection.

9 Nov 2021

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

The Institute of Human Virology (IHV) at the University of Maryland School of Medicine and MitoPower LLC were awarded an SBIR (Small Business Innovation Research) grant of up to $6.5 million over five years from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism.

9 Nov 2021

Medicare enrollment blitz doesn’t include options to move into Medigap

Medicare's annual open-enrollment season is here and millions of beneficiaries — prompted by a massive advertising campaign and aided by a detailed federal website — will choose a private Medicare Advantage plan.

9 Nov 2021

Researchers link elevated levels of galectin-1 with increased risk of type 2 diabetes

Researchers at the University of Gothenburg now associate elevated levels of the protein galectin-1 with increased risk of developing type 2 diabetes about 18 years later.

8 Nov 2021

Identification of a candidate effector gene at COVID-19 risk locus

A new study focuses on developing a comprehensive platform to decode the effects of sequence variation identified by GWAS.

8 Nov 2021

Childhood kidney cancers continue to be diagnosed at later stages in the UK and Ireland

Children with kidney cancers continue to be diagnosed with larger and more advanced tumours in the UK and Ireland than in other Western European countries, according to research presented at the NCRI Festival.

8 Nov 2021

Pacific oyster as a weapon against SARS-CoV-2

According to an article published in the journal Reviews in Medical Virology, the effectiveness of mollusc-derived antiviral agents has been proven in many different laboratory and animal studies, while its efficacy against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been proposed by recent in silico studies.

7 Nov 2021

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

In addition to lowering blood sugar levels, diabetes drugs called sodium-glucose cotransporter 2 (SGLT2) inhibitors can provide kidney- and cardiovascular-related benefits for people with type 2 diabetes.

7 Nov 2021

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

People with kidney failure who are on dialysis or who have received a kidney transplant face a higher risk of dying from COVID-19.

7 Nov 2021

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

A new study by researchers at Hospital for Special Surgery (HSS) in New York City demonstrates over half of patients with rheumatic diseases who contracted COVID-19 during the pandemic and completed a COVID-19 survey, experienced so-called "long-haul" COVID, or prolonged symptoms of the infection, including loss of taste or smell, muscle aches and difficulty concentrating, for one month or longer.

7 Nov 2021

Diabetes medication reduces the rate of kidney function decline in CKD patients

Clinical trial data reveal that dapagliflozin - a sodium-glucose cotransporter 2 inhibitor prescribed to treat diabetes - reduces the rate of kidney function decline in patients with chronic kidney disease (CKD). The findings will be presented at ASN Kidney Week 2021 November 4–November 7.

7 Nov 2021

Oral drug works just as well as conventional therapy for anemia in patients with kidney disease

Anemia is a common and sometimes debilitating problem among patients with chronic kidney disease (CKD). Anemia can occur when the kidneys become damaged, limiting the production of erythropoietin (EPO) - a hormone that signals to the body to make red blood cells.

7 Nov 2021

Results of high-impact clinical trials could affect kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented online at ASN Kidney Week 2021 November 4–November 7.

7 Nov 2021

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.

4 Nov 2021

Inflammatory cytokines may help predict patient outcomes after traumatic injury

Inflammatory cytokines are molecules that are secreted by immune cells to promote inflammation. A study published in the Journal of Orthopaedic Research found that measuring inflammatory cytokines may help predict patient outcomes after traumatic injury, which is the leading cause of mortality in individuals under 50 years of age.

3 Nov 2021

Anti-inflammatory diets in COVID-19

A recent review of research published in the journal Diseases has shown that anti-inflammatory diets can be useful in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or reducing the severity of coronavirus disease 2019 (COVID-19).

3 Nov 2021

Study finds persistent racial gaps in renal complications for children with juvenile lupus

New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, found that while hospitalized children with juvenile lupus have fewer adverse kidney outcomes overall, significant racial gaps for developing these complications persist and do not seem to be narrowing.

2 Nov 2021

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

Researchers at Cedars-Sinai found that patients with inflammatory bowel disease (IBD)─whose treatment can weaken the immune system─produced a strong antibody response to COVID-19 vaccination.

2 Nov 2021

End-stage renal disease negatively impacts COVID-19 vaccine response

Researchers perform a systematic review of people with end-stage kidney disease receiving SARS-CoV-2 vaccines to assess their immunogenicity rates.

2 Nov 2021

Kidney News and Research

Researchers investigate how intestinal bacteria distribute metabolic products in membrane vesicles

SARS-CoV-2 infection regulates protein arginylation

SBIR grant awarded to develop treatment for alcoholic liver disease-associated hepatorenal syndrome

Medicare enrollment blitz doesn’t include options to move into Medigap

Researchers link elevated levels of galectin-1 with increased risk of type 2 diabetes

Identification of a candidate effector gene at COVID-19 risk locus

Childhood kidney cancers continue to be diagnosed at later stages in the UK and Ireland

Pacific oyster as a weapon against SARS-CoV-2

Study examines benefits of SGLT2 inhibitors in individuals with type 1 diabetes

SARS-CoV-2 infection amplifies immune system–related differences in dialysis, kidney transplant patients

Risk factors for "long-haul" COVID in people with rheumatic diseases identified

Diabetes medication reduces the rate of kidney function decline in CKD patients

Oral drug works just as well as conventional therapy for anemia in patients with kidney disease

Results of high-impact clinical trials could affect kidney-related medical care

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Inflammatory cytokines may help predict patient outcomes after traumatic injury

Anti-inflammatory diets in COVID-19

Study finds persistent racial gaps in renal complications for children with juvenile lupus

IBD patients produce a strong antibody response to COVID-19 vaccination, finds study

End-stage renal disease negatively impacts COVID-19 vaccine response

Free guide - Everything about renal proximal tubule cells eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News